References:
1. Ono JG, Kim BI, Zhao Y, Christos PJ, Tesfaigzi Y, Worgall TS, et al.
Decreased sphingolipid synthesis in children with 17q21 asthma-risk
genotypes. J Clin Invest. 2020;130(2):921-6.
2. Calışkan M, Bochkov YA, Kreiner-Møller E, Bønnelykke K, Stein MM, Du
G, et al. Rhinovirus wheezing illness and genetic risk of
childhood-onset asthma. N Engl J Med. 2013;368(15):1398-407.
3. Ketas TJ, Chaturbhuj D, Portillo VMC, Francomano E, Golden E,
Chandrasekhar S, et al. Antibody Responses to SARS-CoV-2 mRNA Vaccines
Are Detectable in Saliva. Pathog Immun. 2021;6(1):116-34.
4. Sattar N, Valabhji J. Obesity as a Risk Factor for Severe COVID-19:
Summary of the Best Evidence and Implications for Health Care. Curr Obes
Rep. 2021;10(3):282-9.
5. Lim ZJ, Subramaniam A, Ponnapa Reddy M, Blecher G, Kadam U, Afroz A,
et al. Case Fatality Rates for Patients with COVID-19 Requiring Invasive
Mechanical Ventilation. A Meta-analysis. Am J Respir Crit Care Med.
2021;203(1):54-66.
6. Green I, Merzon E, Vinker S, Golan-Cohen A, Magen E. COVID-19
Susceptibility in Bronchial Asthma. J Allergy Clin Immunol Pract.
2021;9(2):684-92.e1.
7. Ramakrishnan S, Nicolau DV, Langford B, Mahdi M, Jeffers H, Mwasuku
C, et al. Inhaled budesonide in the treatment of early COVID-19 (STOIC):
a phase 2, open-label, randomised controlled trial. Lancet Respir Med.
2021;9(7):763-72.
8. Rago D, Pedersen CT, Huang M, Kelly RS, Gürdeniz G, Brustad N, et al.
Characteristics and Mechanisms of a Sphingolipid-associated Childhood
Asthma Endotype. Am J Respir Crit Care Med. 2021;203(7):853-63.
9. Törnquist K, Asghar MY, Srinivasan V, Korhonen L, Lindholm D.
Sphingolipids as Modulators of SARS-CoV-2 Infection. Front Cell Dev
Biol. 2021;9:689854.